Search
AUA 2016: Repeat Biopsy: State-of-the-Art Patient Selection and Technique - Session Highlights
- E. David Crawford, MD
- May 11, 2016
- 1 min read
Dr. Crawford discusses the use of PSA as well as a new treatment algorightm he developed to better determine which men should be further screened with biopsy/genomic testing with a PSA greater than or equal to 1.5. Click here to learn more
Recent Posts
See AllDr(s) David Crawford and Marc Garnick discuss the new 2017 USPSTF recommendations and how this impacts PSA screening. Click here to learn...
Dr. Crawford discusses the TERRAIN and STRIVE studies and their impact on castrate resistant prostate cancer. Click here to learn more.
Dr. Crawford discusses the surprising trend of how there is a decline in prostate cancer screening amongst primary care docs. Click here...